Skip to main content

Assessing the risk of contagion from a slump in US equities

One of our key calls for 2022 is that mid- and large-cap equities in the US will generally underperform those in other developed markets, and only fare about as well on average as those in emerging markets, as the Fed raises rates. Nonetheless, this is a call about relative performance, made in the context of our forecast that the S&P 500 will eke out a small gain this year. If, instead, it suffered a major drawdown, we don’t think major stock market indices outside the US would be spared.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.